Table 3.
Adverse events (%) and treatment discontinuation
Adverse events (73.9%) | |
Anemia | 52.9 |
Asthenia | 39.6 |
Neutro/thrombopenia | 29.6 |
Dysgeusia | 8.6 |
Psychiatric disorders | 6.7 |
Anorectal symptoms | 5.9 |
Others (see text) | 14.9 |
Treatment discontinuation (122 cases; 14.6%) | Number of cases |
Rash/Itch | 36 (29.5%) |
Anemia | 28 (22.9%) |
Asthenia | 18 (14.7%) |
Psychiatric disorders | 6 (5%) |
Pancytopenia | 3 (2.5%) |
Neutro/thrombopenia | 3 (2.5%) |
Others (see text) | 28 (22.9%) |